Table 2 Typical COVID-19 symptoms frequency at acute and LC phases and respective persistence
Symptom | Phase of COVID-19 disease course | Persistence of symptoms between phases | ||
|---|---|---|---|---|
Acute COVID-19*1, n (%) | Long COVID (LC)*2, n (%) | Persistent symptoms*3 n (%) | New-onset symptoms*4 n (%) | |
Myalgia | 118 (50%) | 38 (16.1%) | 27 (11.4%) | 11 (4.7%) |
Hyposmia/anosmia | 114 (48.3%) | 37 (15.7%) | 27 (11.4%) | 10 (4.2%) |
Dysgeusia/ageusia | 108 (45.8%) | 26 (11%) | 22 (9.3%) | 4 (1.7%) |
Fever | 83 (35.2%) | 4 (1.7%) | 3 (1.3%) | 1 (0.4%) |
Fatigue | 80 (33.9%) | 50 (21.2%) | 23 (9.7%) | 27 (11.4%) |
Dry cough | 74 (31.4%) | 14 (5.9%) | 6 (2.5%) | 8 (3.4%) |
Coriza | 49 (20.8%) | 10 (4.2%) | 4 (1.7%) | 6 (2.5%) |
Dyspnea | 51 (21.6%) | 32 (13.6%) | 12 (5.1%) | 20 (8.5%) |
Sore throat | 41 (17.4%) | 9 (3.8%) | 5 (2.1%) | 4 (1.7%) |
Diarrhea | 39 (16.5%) | 7 (3%) | 2 (0.8%) | 5 (2.1%) |
Headache | 110 (46.6%) | 45 (19.1%) | 29 (12.3%) | 16 (6.8%) |
Nausea/vomiting | 34 (14.4%) | 17 (7.2%) | 6 (2.5%) | 11 (4.7%) |
Loss of appetite | 34 (14.4%) | 4 (1.7%) | 0 (0%) | 4 (1.7%) |
Abdominal pain | 23 (9.7%) | 4 (1.7%) | 1 (0.4%) | 3 (1.3%) |
Expectoration | 13 (5.5%) | 4 (1.7%) | 2 (0.8%) | 2 (0.8%) |